EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. Market Sentiment

Market sentiment signals for EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. (EVFM): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— N/A

Short Interest— 0.0% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

—

1 analysts

Options Flow (P/C)

—

Avg Consensus PT

—

Highest Price Target

—

Lowest Price Target

—

Short Interest

0.0%

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Dec 13, 2023	Laidlaw & Co.	Yale Jen—	—	—	Downgrade	Buy→Hold

Insider & Market Activity News

PRO
Evofem Biosciences CEO Buys 141K Shares At Average Price Of $0.35/Share

-SEC Filing

Benzinga Newsdesk

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Stocks That Hit 52-Week Lows On Thursday

During Thursday, 351 stocks hit new 52-week lows.

Benzinga Insights

Stocks That Hit 52-Week Lows On Tuesday

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Benzinga Insights

Stocks That Hit 52-Week Lows On Monday

On Monday, 466 companies hit new 52-week lows.

Benzinga Insights

Stocks That Hit 52-Week Lows On Friday

During Friday's morning session, 234 stocks hit new 52-week lows.

Benzinga Insights

Benzinga

Benzinga